Galderma Group AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	839	780	457	368
Cash & Short-Term Investments	839	780	457	368
Cash Growth	7.56%	70.68%	24.19%	-
Accounts Receivable	1,077	1,044	892	750
Inventory	650	525	403	420
Other Current Assets	82	87	91	78
Total Current Assets	2,649	2,437	1,843	1,616
Net Property, Plant & Equipment	789	744	577	529
Other Intangible Assets	4,521	4,639	4,829	4,923
Goodwill	5,129	5,129	5,129	5,129
Long-Term Investments	1	3	1	10
Other Long-Term Assets	438	442	238	264
Total Assets	13,526	13,393	12,617	12,471
Accounts Payable	1,015	943	676	653
Accrued Expenses	933	912	705	654
Current Portion of Long-Term Debt	63	65	36	63
Other Current Liabilities	123	133	109	201
Total Current Liabilities	2,133	2,055	1,528	1,571
Long-Term Debt	2,653	2,689	2,723	4,846
Long-Term Leases	1	1	2	10
Other Long-Term Liabilities	526	499	574	675
Total Long-Term Liabilities	3,178	3,189	3,299	5,531
Total Liabilities	5,311	5,243	4,827	7,102
Common Stock	1,988	2,092	2,136	6,259
Treasury Stock	-669	-378	-15	-
Additional Paid-in Capital	66	64	48	43
Accumulated Other Comprehensive Income	32	25	-55	-32
Retained Earnings	6,798	6,347	5,676	-901
Shareholders' Equity	8,215	8,149	7,790	5,369
Total Liabilities & Equity	13,526	13,393	12,617	12,471
Total Debt	2,717	2,755	2,761	4,919
Net Cash (Debt)	-1,878	-1,975	-2,304	-4,551
Net Cash Growth	-	-	-	-
Net Cash Per Share	-7.97	-8.33	-9.69	-19.16
Book Value	8,215	8,149	7,790	5,369
Book Value Per Share	34.88	34.38	32.76	22.60
Tangible Book Value	-1,435	-1,619	-2,168	-4,683
Tangible Book Value Per Share	-6.09	-6.83	-9.12	-19.71